Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Improved Cryopreservation of Human Hepatocytes Using a New Xeno-Free Cryoprotectant Solution

Published: Saturday, July 07, 2012
Last Updated: Monday, July 09, 2012
Bookmark and Share
Researchers from the Karolinska Institute have optimized a cryoprotectant combination, which may be a better alternative to the standard DMSO-UW protocol in primary human hepatocyte cryopreservation.

Aim:
To optimize a xeno-free cryopreservation protocol for primary human hepatocytes.

Methods:
The demand for cryopreserved hepatocytes is increasing for both clinical and research purposes. Despite several hepatocyte cryopreservation protocols being available, improvements are urgently needed. We first compared controlled rate freezing to polystyrene box freezing and did not find any significant change between the groups. Using the polystyrene box freezing, we compared two xeno-free freezing solutions for freezing of primary human hepatocytes: a new medium (STEM-CELLBANKER, CB), which contains dimethylsulphoxide (DMSO) and anhydrous dextrose, both permeating and non-permeating cryoprotectants, and the frequently used DMSO - University of Wisconsin (DMSO-UW) medium. The viability of the hepatocytes was assessed by the trypan blue exclusion method as well as a calcein-esterase based live-dead assay before and after cryopreservation. The function of the hepatocytes was evaluated before and after cryopreservation by assessing enzymatic activity of 6 major cytochrome P450 isoforms (CYPs): CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4 and CYP3A7.

Results:
The new cryoprotectant combination preserved hepatocyte viability significantly better than the standard DMSO-UW protocol (P < 0.01). There was no significant difference in viability estimation between both the trypan blue (TB) and the Live-Dead Assay methods. There was a correlation between viability of fresh hepatocytes and the difference in cell viability between CB and DMSO protocols (r(2) = 0.69) using the TB method. However, due to high within-group variability in the activities of the major CYPs, any statistical between-group differences were precluded. Cryopreservation of human hepatocytes using the cryoprotectant combination was a simple and xeno-free procedure yielding better hepatocyte viability. Thus, it may be a better alternative to the standard DMSO-UW protocol. Estimating CYP activities did not seem to be a relevant way to compare hepatocyte function between different groups due to high normal variability between different liver samples.

The article is published online in the World Journal of Hepatology and is free to access.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biobanking in a Constantly Developing Medical World
Biomaterial resources such as tissues, cells, blood, and serum have played a critical role in academic research.
Wednesday, November 06, 2013
International Heart Valve Bank Survey: A Review of Processing Practices and Activity Outcomes
Since the first heart valve bank (HVB) started in New Zealand in 1962, the recovery, processing, and storage techniques have been constantly evolving.
Wednesday, November 06, 2013
Developing a Semantically Rich Ontology for the Biobank-Administration Domain
Recent research has provided compelling examples of using semantic web technologies, such as ontologies, to retrieve research-relevant data from biobanks.
Tuesday, October 15, 2013
Patient Understanding and Awareness of their Roles as Research Stakeholders in a Cancer Biobank
A patient’s informed consent should imply that the patient has received complete information and fully understands its meaning.
Tuesday, September 10, 2013
Telethon Network of Genetic Biobanks: a Key Service for Diagnosis and Research on Rare Diseases
Recent advances in the technology of molecular biology and genetics have contributed to raise the awareness of the importance of coordinated biobanking activity.
Tuesday, September 10, 2013
Synthetic Surface for Expansion of Human Mesenchymal Stem Cells in Xeno-Free, Chemically Defined Culture
This study evaluates the ability of the Corning Synthemax Surface to support long-term expansion of hMSCs in serum-free, defined medium.
Friday, August 16, 2013
Cryopreservation Causes Genetic and Epigenetic Changes in Zebrafish Genital Ridges
Recent studies have pointed out that cryopreservation can cause molecular alterations in cells at different levels that may interfere with normal embryo development.
Thursday, July 18, 2013
BioBanking as the Central Tool for Translational Medicine
Global healthcare changes forms the basis for the rapid development of centralized large scale biobank facilities.
Monday, June 24, 2013
Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
Current research developments and future healthcare solutions are expected to be closely linked to the utility of biobank initiatives.
Friday, March 22, 2013
Effect of Different Freezing Rates During Cryopreservation of Rat MSCs using Combinations of HES and DMSO
In this study researchers from Fraunhofer Institute for Cell Therapy and Immunology attempt an initial comparison of two independent factors: freezing rates and cryopreservation.
Thursday, November 08, 2012
Cryopreserved Reticulocytes Derived from Stem Cells can be Invaded by Cryopreserved Plasmodium vivax Isolates
The cryopreservation method described in this paper provides a continuous and substantial source of reticulocytes, possibly a first step to achieve the continuous in vitro culture of P. vivax.
Wednesday, November 07, 2012
New national Biobank of The Danish Center for Strategic Research on Type 2 Diabetes
This paper aims to describe the biobank logistics and how the biological samples are collected, handled, shipped and stored.
Friday, November 02, 2012
Human Blood RNA Stabilization in Samples Collected and Transported for a Large Biobank
The study strongly suggests that special collection tubes are necessary for RNA stabilization and they should be used for establishing new biobanks.
Friday, October 05, 2012
Biobanking for Health Research in Brazil: Present Challenges and Future Directions
This article outlines and discusses Brazil's new regulations on the use of human biological materials for research.
Monday, September 10, 2012
Evaluation of Distinct Freezing Methods and Cryoprotectants for Human Amniotic Fluid Stem Cells Cryopreservation
Researchers from the University of São Paulo Medical School have evaluated the effects of two cryopreservation methods and four distinct cryoprotectants in the AFSCs viability and main characteristics maintenance after liquid nitrogen storage.
Monday, August 06, 2012
Scientific News
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Rapidly Generating Bone, Heart Muscle
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
New Mechanism of Tuberculosis Infection
Researchers have identified a new infection mechanism of tuberculosis that could lead to a new therapeutic angle.
Modelling ALS Requires ‘Aged’ Stem Cells
Research suggests engineered cells are too ‘young’ to accurately model ALS and should be 'aged' to speed progress toward finding potential treatments.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
HIV Hides No Longer
Researchers are working to create proteins that clear HIV-infected cells in order to eliminate latent infection and dormancy.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!